Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19

NCT04476979 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04476979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04476979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Phase 2
Overall status
Completed
Start date
July 16, 2020
Completion date
August 11, 2021
Enrollment
453 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronaviridae infections, coronavirus infection, nidovirales infections, respiratory tract disease, respiratory tract infections, rna virus infections, sars (severe acute respiratory syndrome), virus diseases